Report Description

Global lipid based formulations market is anticipated to grow with an impressive CAGR in the forecast period, 2023-2027, on account of growing pharmaceutical industry. Rapidly surging demands for the advanced medicine and growing demand for oral administrated medicine is driving the growth of the global lipid formulations market in the upcoming five years.

Lipid based formulations are bio-chemical compounds that are artificially synthesized to facilitate the drug administration, while ensuring safety of the drug along with bio-solubility of it for the digestion and faster action of the main drug component inside the formulation. Lipid based formulations aid the primary mechanism of action for the drug that leads to bioavailability.

In simpler terms, highly water soluble drugs if gets dissolved in the starting of gut, may not reach the target site, or target organ and thus its efficiency decreases. To alter this effect, a lipid based formulation is utilized. Lipids form a hydrophobic bonds around the drug and avoid dissolution partially or completely until it reaches the target site. With digestion of the lipid bonds by the process of triglyceride digestion, the drug gets delivered in the later parts of gastrointestinal tract.

Pharmaceutical Advancements Drive Market Growth

Consistent research and development of the drugs such that they have higher bio-availability, higher effect on the target site, to improve facilitation of the drug to create its effect at the target site, is driving the growth of the global lipid based formulations market in the upcoming five years. A major concern among the drug delivery system is that, for the oral administration of the drug, it has tendency to get dissolved or digested before reaching the target site.

In such cases, the drug if get dissolved would leave the gastrointestinal tract without being absorbed in the blood. To avoid this untimely dissolution, lipid based formulations are utilized to enhance the drug durability and absorption thus substantially increasing its affinity as a treatment for a particular diseases.

Growing Investments In Healthcare Industry Supports Market

Governments from major economies are actively investing in their respective healthcare sectors to enhance the services and products such that best possible patient care can be provided. Increasing instances of chronic, infectious, and communicable diseases, is further anticipated to drive the growth of the global lipid based formulations market in the upcoming five years.

Consistent research and technological advancement for the pharmaceutical product development and advancement of the drug delivery systems, is also anticipated to substantiate the growth of the global lipid based formulations market in the future five years.


Click here to download the sample

Market Segmentation

The global lipid based formulations market segmentation is based on source of lipids, application, distribution channel, regional distribution, and competitive landscape. Based on source of lipids, the market is differentiated between natural and chemically synthesized sources. Application based segments of the market is distinguished among fungal diseases, oncology, gene therapy, antiviral vaccines, and others.

Based on distribution channel, the market is fragmented into retail pharmacies, hospital pharmacies, and online pharmacies. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc., are enlisted in a partial list of major market players of the global lipid based formulations market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

  • Source of Lipid
  • Application
  • Distribution Channel

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia.

Key companies profiled

Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global lipid based formulations market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Lipid Based Formulations Market, By Source of Lipids:
    • Natural
    • Chemically Synthesized
  • Lipid Based Formulations Market, By Application:
    • Fungal Diseases
    • Oncology
    • Gene Therapy
    • Antiviral Vaccines
    • Others
  • Lipid Based Formulations Market, By Distribution Channel:
    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
  • Lipid Based Formulations Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global lipid based formulations market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Lipid based formulations Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Lipid Based Formulations Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Preference, By Source of Lipids

5.2.  Factors Contributing to Demand for Lipid Based Formulations

5.3.  Barriers to Adoption of Lipid Based Formulations

5.4.  Brand Awareness

6.    Clinical Trials

6.1.  Ongoing Clinical Trials

6.2.  Completed Clinical Trials

6.3.  Terminated Clinical Trials

6.4.  Clinical Trial Analysis

7.    Patent Analysis

7.1.  Patent Granted (2017-2021)

7.2.  Patent Applications Filed

8.    List of Commercially Available Lipid Based Formulations

9.    Global Lipid Based Formulations Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Source of Lipids (Natural v/s Chemically Synthesized)

9.2.2.     By Application (Fungal Diseases, Oncology, Gene Therapy, Antiviral Vaccines, Others)

9.2.3.     By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)

9.2.4.     By Company (2021)

9.2.5.     By Region

9.3.  Product Market Map

10.  North America Lipid Based Formulations Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Source of Lipids

10.2.2.  By Application

10.2.3.  By Distribution Channel

10.2.4.  By Country

10.3.              North America: Country Analysis

10.3.1.  United States Lipid Based Formulations Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Source of Lipids

10.3.1.2.2.           By Application

10.3.1.2.3.           By Distribution Channel

10.3.2.  Mexico Lipid Based Formulations Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Source of Lipids

10.3.2.2.2.           By Application

10.3.2.2.3.           By Distribution Channel

10.3.3.  Canada Lipid Based Formulations Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Source of Lipids

10.3.3.2.2.           By Application

10.3.3.2.3.           By Distribution Channel

11.  Europe Lipid Based Formulations Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Source of Lipids

11.2.2.  By Application

11.2.3.  By Distribution Channel

11.2.4.  By Country

11.3.              Europe: Country Analysis

11.3.1.  France Lipid Based Formulations Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Source of Lipids

11.3.1.2.2.           By Application

11.3.1.2.3.           By Distribution Channel

11.3.2.  Germany Lipid Based Formulations Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Source of Lipids

11.3.2.2.2.           By Application

11.3.2.2.3.           By Distribution Channel

11.3.3.  United Kingdom Lipid Based Formulations Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Source of Lipids

11.3.3.2.2.           By Application

11.3.3.2.3.           By Distribution Channel

11.3.4.  Italy Lipid Based Formulations Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Source of Lipids

11.3.4.2.2.           By Application

11.3.4.2.3.           By Distribution Channel

11.3.5.  Spain Lipid Based Formulations Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Source of Lipids

11.3.5.2.2.           By Application

11.3.5.2.3.           By Distribution Channel

12.  Asia-Pacific Lipid Based Formulations Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Source of Lipids

12.2.2.  By Application

12.2.3.  By Distribution Channel

12.2.4.  By Country

12.3.              Asia-Pacific: Country Analysis

12.3.1.  China Lipid Based Formulations Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Source of Lipids

12.3.1.2.2.           By Application

12.3.1.2.3.           By Distribution Channel

12.3.2.  India Lipid Based Formulations Market Outlook

12.3.2.1.      Market Size & Forecast

12.3.2.1.1.           By Value

12.3.2.2.      Market Share & Forecast

12.3.2.2.1.           By Source of Lipids

12.3.2.2.2.           By Application

12.3.2.2.3.           By Distribution Channel

12.3.3.  South Korea Lipid Based Formulations Market Outlook

12.3.3.1.      Market Size & Forecast

12.3.3.1.1.           By Value

12.3.3.2.      Market Share & Forecast

12.3.3.2.1.           By Source of Lipids

12.3.3.2.2.           By Application

12.3.3.2.3.           By Distribution Channel

12.3.4.  Japan Lipid Based Formulations Market Outlook

12.3.4.1.      Market Size & Forecast

12.3.4.1.1.           By Value

12.3.4.2.      Market Share & Forecast

12.3.4.2.1.           By Source of Lipids

12.3.4.2.2.           By Application

12.3.4.2.3.           By Distribution Channel

12.3.5.  Australia Lipid Based Formulations Market Outlook

12.3.5.1.      Market Size & Forecast

12.3.5.1.1.           By Value

12.3.5.2.      Market Share & Forecast

12.3.5.2.1.           By Source of Lipids

12.3.5.2.2.           By Application

12.3.5.2.3.           By Distribution Channel

13.  South America Lipid Based Formulations Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Source of Lipids

13.2.2.  By Application

13.2.3.  By Distribution Channel

13.2.4.  By Country

13.3.              South America: Country Analysis

13.3.1.  Brazil Lipid Based Formulations Market Outlook

13.3.1.1.      Market Size & Forecast

13.3.1.1.1.           By Value

13.3.1.2.      Market Share & Forecast

13.3.1.2.1.           By Source of Lipids

13.3.1.2.2.           By Application

13.3.1.2.3.           By Distribution Channel

13.3.2.  Argentina Lipid Based Formulations Market Outlook

13.3.2.1.      Market Size & Forecast

13.3.2.1.1.           By Value

13.3.2.2.      Market Share & Forecast

13.3.2.2.1.           By Source of Lipids

13.3.2.2.2.           By Application

13.3.2.2.3.           By Distribution Channel

13.3.3.  Colombia Lipid Based Formulations Market Outlook

13.3.3.1.      Market Size & Forecast

13.3.3.1.1.           By Value

13.3.3.2.      Market Share & Forecast

13.3.3.2.1.           By Source of Lipids

13.3.3.2.2.           By Application

13.3.3.2.3.           By Distribution Channel

14.  Middle East and Africa Lipid Based Formulations Market Outlook

14.1.              Market Size & Forecast

14.1.1.  By Value

14.2.              Market Share & Forecast

14.2.1.  By Source of Lipids

14.2.2.  By Application

14.2.3.  By Distribution Channel

14.2.4.  By Country

14.3.              MEA: Country Analysis

14.3.1.  South Africa Lipid Based Formulations Market Outlook

14.3.1.1.      Market Size & Forecast

14.3.1.1.1.           By Value

14.3.1.2.      Market Share & Forecast

14.3.1.2.1.           By Source of Lipids

14.3.1.2.2.           By Application

14.3.1.2.3.           By Distribution Channel

14.3.2.  Saudi Arabia Lipid Based Formulations Market Outlook

14.3.2.1.      Market Size & Forecast

14.3.2.1.1.           By Value

14.3.2.2.      Market Share & Forecast

14.3.2.2.1.           By Source of Lipids

14.3.2.2.2.           By Application

14.3.2.2.3.           By Distribution Channel

14.3.3.  UAE Lipid Based Formulations Market Outlook

14.3.3.1.      Market Size & Forecast

14.3.3.1.1.           By Value

14.3.3.2.      Market Share & Forecast

14.3.3.2.1.           By Source of Lipids

14.3.3.2.2.           By Application

14.3.3.2.3.           By Distribution Channel

15.  Market Dynamics

15.1.              Drivers

15.2.              Challenges

16.  Market Trends & Developments

17.  Competitive Landscape

17.1.              Novartis AG

17.2.              AbbVie, Inc.

17.3.              F. Hoffmann-La Roche AG

17.4.              Johnson & Johnson

17.5.              Alnylam Pharmaceuticals Inc.

18.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Advancing healthcare industry and consistent research are driving the growth of the global lipid based formulations market in the upcoming five years.

down-arrow

The global lipid based formulations market is segmented into North America region, South America region, Asia Pacific region, European region, and Middle East & Africa region for the regional analysis of the market. North America region is anticipated to dominate the market analysis in the upcoming five years on the account of increasing research and product development along with increasing investment in the procedure in recent years.

down-arrow

Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc., among others are some of the leading companies dedicated toward providing related products and services of lipid based formulations and support the future growth of the global lipid based formulations market in the upcoming five years.

down-arrow

The global lipid based formulations market analysis was analyzed for the five historical years from 2017 to 2020. Keeping the base year 2020 as the margin, the estimation for the year 2022 was made and further market growth is predicted for the forecast years, 2023 to 2027.

profile

Sakshi Bajaal

Business Consultant
Press Release

Lipid Based Formulations Market to Grow with an Impressive CAGR During the Forecast Period

Jan, 2022

Global Lipid based formulations Market is driven by increasing demand for effective oil production in the forecast period, 2023-2027.